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Background: Environmental factors, including socioeconomic status, may affect inflammatory 
bowel disease (IBD). There is a paucity of data on the epidemiology of IBD among patients of 
low socioeconomic status.
Aim: To examine the epidemiologic features of IBD among African-American, Hispanic, and 
Caucasian patients from a county hospital, where the majority of the patients are socioeconomi-
cally disadvantaged.
Methods: A retrospective study was conducted on a cohort of patients diagnosed with IBD 
based on clinical, radiologic, endoscopic, and histological data. We reviewed charts of adults aged 
20–70 years diagnosed with IBD between 2000 and 2006. Demographic data, disease subtype, 
and phenotypic features of IBD were recorded based on the Montreal Classification. The data 
were analyzed using the chi-square, Fisher exact, Wilcoxon rank-sum, and Student’s t-tests.
Results: The study cohort included 273 patients, with 54% female, 30% Caucasian, 44% 
  African-American, and 26% Hispanic. Over half (54%) of the patients had Crohn’s disease 
(CD), and 46% had ulcerative colitis (UC). The mean age at diagnosis was 40 ± 14 years with 
no   significant difference between CD and UC (age 43 ± 13 versus 44.5 ± 14, respectively; 
P = 0.5). Females were diagnosed at a significantly later age than males (46 ± 13 years versus 
40 ± 13, respectively; P = 0.001). This trend remained significant for females with CD and UC, 
and across each racial/ethnic group. Hispanic patients were diagnosed with UC more often than 
  Caucasian patients (64% versus 34%; odds ratio [OR] 3.5; 95% confidence interval [CI]: 1.8–6.5, 
P = 0.0003) or African-Americans (64% versus 43%; OR 2.3; 95% CI: 1.3–4.3, P = 0.005). 
Among the 147 patients with CD, 54% had fistulizing and/or stricturing disease. The prevalence 
of   fistulizing, stricturing, and inflammatory CD was similar across all age, gender, and racial/
ethnic groups.
Conclusions: Within an indigent population, UC was diagnosed more often in Hispanics than 
CD. Females were diagnosed at a significantly older age than males across all racial/  ethnic 
groups. There was no difference in the CD phenotypes between the three ethnic groups. 
  Understanding the epidemiology of IBD will require examination of the interactions between 
gender, race/  ethnicity, and environmental factors.
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Introduction
The term inflammatory bowel disease (IBD) includes Crohn’s disease (CD) and 
  ulcerative colitis (UC) and is ranked among the five most prevalent gastrointestinal 
diseases in the United States.1 IBD is estimated to affect over one million patients 
in the United States and be responsible for annual health care costs exceeding 
US$1.7   billion.1–4 The etiology and the natural history of IBD are both influenced Clinical and Experimental Gastroenterology 2010:3 submit your manuscript | www.dovepress.com
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by   environmental and genetic factors. IBD is considered a 
complex polygenic disorder in which the genotypic profile 
influences the disease characteristics.5–6 Environmental 
exposures such as cultural background, socioeconomic 
  status, and diet are also important, although data concerning 
environmental–genetic interactions are sparse.5
Our current understanding of the epidemiology, prognosis, 
and treatment of IBD is currently based primarily on studies 
conducted in Caucasian populations,7–9 despite the fact that 
over the last two decades the incidence of hospitalizations for 
IBD among African-Americans has begun to approach that of 
Caucasians.10–12 Our aim was to examine the   epidemiologic 
features of IBD among multiethnic patients in a county 
hospital that primarily serves patients of low socioeconomic 
status. We also evaluated these patients for differences in IBD 
phenotype between racial/ethnic groups.
Materials and methods
Study design
We performed a cross-sectional study of all patients with 
IBD treated in the Harris County Hospital District (HCHD) 
between 2000 and 2006. Patients with IBD were identified 
using diagnostic codes from the International Classification 
of Disease (ICD) 9th (555.x [CD] and 556.x [UC]) and 10th 
editions (K50.x [CD] and K51.x [UC]). Primary medical 
record review was performed by a gastroenterologist (JKH) 
using a standardized abstraction form.
The diagnosis of IBD was confirmed based on   findings 
consistent with current practice criteria. Patients with a his-
tory of bowel resection prior to seeking care within the HCHD 
were eligible for inclusion without histologic   confirmation. 
Perianal surgery included fistulotomy, abscess drainage, 
or seton placement. Patients with a non-IBD   diagnosis on 
  follow-up (infection, ischemia, or malignancy) or indeter-
minate colitis were excluded, as were patients under the age 
of 18 years.
Study setting
HCHD comprises three inpatient facilities and 13 outpatient 
clinics and serves the residents of the third most populous 
county in the United States. Over 40,000 hospital admissions 
and more than 900,000 clinic visits occurred in the HCHD 
between 2000 and 2006.14 Sixty percent of the patients are 
charity/self-pay and nearly 60% are Hispanic. More than 
half of the patients in the HCHD are female (HCHD internal 
data source). This study was conducted with the approval 
of the Baylor College of Medicine and HCHD Institutional 
Review Boards.
Data collection
The HCHD uses the EpicWeb (Epic Systems Incorporated, 
Wisconsin, MN, USA) electronic medical record (EMR) 
system. This EMR contains laboratory, endoscopy, radiology, 
and pathology reports; limited inpatient records (admission 
history and physical and discharge summaries); and ambula-
tory care records.
Demographic data including age, gender, and race/
ethnicity were recorded for each study patient. Race/ethnicity 
was based on patient self-report in the medical record. Only 
data involving African-American, Caucasian, and Hispanic 
patients were included in this study due to the small sample 
size of the other ethnic groups.
IBD characteristics were recorded for each study patient. 
CD and UC location and phenotype were classified according 
to the Montreal Classification. The extent of UC was deter-
mined based on evidence of endoscopic or histological activity. 
The phenotype of CD was identified as fistulizing, stricturing, 
or inflammatory disease based on available data.
Statistical analysis
Categorical variables were compared using chi-square and 
ANOVA tests. Continuous variables were compared using 
Wilcoxon rank-sum and Student’s t-tests. Age was analyzed 
as a continuous variable and was also categorized into five 
groups by each decade. Statistical analysis was performed 
using SAS version 4.0 Software.13
Results
The study cohort included 273 patients with 54% female, 30% 
Caucasian, 44% African-American, and 26% Hispanic. Over 
half of the patients had CD and 46% had UC (Table 1). The 
mean age at diagnosis was 40 ± 14 years with no significant 
difference between CD and UC (age 43 ± 13 versus 44.5 ± 14, 
respectively; P = 0.5). Female patients with IBD were diag-
nosed at a significantly later age than male patients, and this 
trend was consistent for both CD and UC. Although this trend 
was seen among all three racial/ethnic groups, it was signifi-
cant among the African-American patients. Hispanic patients 
were diagnosed with UC more often than Caucasian (64% 
versus 34%; odds ratio [OR] 3.5; 95% confidence interval 
[CI]: 1.8–6.5, P = 0.0003) or African-American patients (64% 
versus 43%; OR 2.3; 95% CI: 1.3–4.3, P = 0.005). Caucasians 
were diagnosed with CD more often than UC (Figure 1).
Crohn’s disease characteristics
The prevalence of the inflammatory phenotype was 
significantly greater than stricturing disease (65% versus Clinical and Experimental Gastroenterology 2010:3 submit your manuscript | www.dovepress.com
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16%, OR 4.1, 95% CI: 2.5–7.0, P = 001) or fistulizing 
disease (65% versus 19%, OR 3.4, 95% CI: 2.1–5.5, 
P = 0.001). The fistulizing phenotype was seen twice as 
often in Hispanics than Caucasians or African-Americans, 
although this did not reach statistical significance, possibly 
due to the small sample size (32% versus 17%, OR 2.0, 95% 
CI: 0.7–5.5, P = 0.20, versus 16%, OR 2.2, 95% CI: 0.7–5.2, 
P = 0.18, respectively) (Figure 2). The overall rate of fistu-
lizing, stricturing, and inflammatory CD was similar across 
all age groups and between male and female patients.
Table 1 The mean age of diagnosis/presentation of inflammatory bowel disease by gender among the 273 adults in the study
All patients (N = 273) Crohn’s disease (N = 147) Ulcerative colitis (N = 126)
Total 
number
Mean 
age 
± SD P Total 
number
Mean 
age
± SD P Total 
number
Mean 
age
± SD P
Total population 
Males 
Females
125 
148
40.1 
46.4
13.9 
13.9
0.02* 63 
84
38.2 
46.0
15.1 
13.0
0.001* 62 
64
41.5 
47.0
13.5 
15.3
0.03*
African-Americans 
Males 
Females
48 
72
39.2 
48.1
14.1 
13.8
0.001* 30 
38
38.8 
46.1
13.9 
13.1
0.03* 18 
34
40.5 
50.4
14.1 
14.0
0.02*
Caucasians 
Males 
Females
37 
46
41.2 
44.1
13.5 
13.1
0.65 18 
36
36.8 
44.4
13.6 
12.8
0.05* 19 
10
44.6 
40.5
12.4 
14.8
0.45
Hispanics 
Males 
Females
40 
30
40.2 
46.1
15.0 
15.2
0.08 15 
10
39.0 
50.5
19.6 
11.4
0.07 25 
20
39.9 
44.4
14.1 
16.8
0.34
Note: *P is significant at levels <0.05. 
Abbreviation: SD, standard deviation.
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Figure 1 The CD:UC ratio among the total study population by race/ethnicity. Hispanics were diagnosed more often with UC than with CD, Caucasians were diagnosed 
more often with CD than with UC, and African-Americans were diagnosed more often with CD than with UC, but the difference was not significant. 
Notes: *P is significant at levels <0.05. **P is significant at levels <0.001.
Abbreviations: IBD; inflammatory bowel disease; CD, Crohn’s disease; UC, ulcerative colitis.Clinical and Experimental Gastroenterology 2010:3 submit your manuscript | www.dovepress.com
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Ulcerative colitis characteristics
The majority of the patients (62%) with UC had pancolitis, 
27% had left-sided colitis, and 11% had proctitis. This distri-
bution was similar across all racial/ethnic groups. The mean 
age of patients with left-sided colitis was significantly higher 
than those with pancolitis or proctitis (age 50 ± 14.1 versus 
41.5 ± 14.4, 41.2 ± 13.4, respectively; P = 0.05). Females 
had a significantly higher rate of left colitis than males (30% 
versus 13%, OR 2.1, 95% CI: 1.1–5.4, P = 0.001). Males 
had a higher rate of pancolitis than females, but that differ-
ence was not significant (56% versus 42%, OR 1.3, 95% 
CI: 0.6–2.1, P = 0.60).
Discussion
Although IBD has been reported worldwide, most studies 
have focused on the Caucasian populations, and there is 
still a paucity of literature on the epidemiologic aspects of 
the disease in Hispanics and African-Americans. Moreover, 
IBD has not previously been studied in populations of low 
  socioeconomic status. In this study of a multiethnic IBD 
  population of   predominantly low socioeconomic status, we 
found that   Hispanics were diagnosed with UC more than CD. 
Our   findings are consistent with the results reported from 
Puerto Rico that showed that a higher proportion of study 
patients were diagnosed with UC than with CD.13–15 This 
  finding was also reported in another United States study in 
which Mexican-Americans predominantly had UC, compared 
with Caucasians and African-Americans, who predominantly 
had CD.16 An earlier study from a health maintenance organiza-
tion database in California found that Hispanics had a lower 
prevalence of CD compared with both African-Americans 
and Caucasians.17 A systematic review of 28 publications 
encompassing 1272 Hispanic and 547 African-American 
patients with IBD found that a greater proportion of Hispanic 
patients were diagnosed with UC than with CD compared 
with African-American patients.18 On the contrary, Nguyen 
et al reported a higher frequency of CD compared with UC 
among a Puerto Rican population.11 This dissimilarity in the 
study results could be due to differences in the study design, 
the characteristics of the study population, or the differences 
in the genetic and environmental exposure(s) of the studied 
population.
The difference in the distribution rate of CD and UC across 
the three racial/ethnic groups emphasizes the potential role of 
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Figure 2 The distribution rates of Crohn’s disease (CD) phenotype by race/ethnicity among the 147 patients with CD. Hispanics have twice the rate of fistualzing disease 
than African-Americans or Caucasians. There were no significant differences in the distribution rates of inflammation and strictures between the three ethnic groups.Clinical and Experimental Gastroenterology 2010:3 submit your manuscript | www.dovepress.com
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genetics and environmental interaction on the   etiology of IBD. 
A recent study reported that African-  American and Hispanic CD 
patients, but not UC patients, had a lower prevalence of family 
history of IBD than their Caucasian counterparts, concluding that 
racial differences may reflect underlying genetic variations.11 It 
is also worth pointing out that differences in diet and hygiene are 
changing over time and could play a role in the etiology of IBD. 
The high-fat intake diet among the African-American population 
could possibly contribute to the etiology of CD. A study from the 
United States among urban African-Americans found 77% of the 
study population had a diet that is very high in fat.19
The second novel finding of our study is the difference 
in the mean age of diagnosis between females and males. 
Female patients with IBD were diagnosed at a significantly 
older age than males. Although this trend was consistent 
among the three ethnic groups for UC, it was reversed among 
Caucasians diagnosed with CD, as males were diagnosed later 
than females. This observation was not previously reported, 
and the clear reason for that difference is unknown. This 
finding could be due to true gender differences or because 
women had sought medical care for their symptoms later than 
men. It is less likely to be due to a high proportion of women 
treated in the studied hospital because, based on an HCHD 
internal source (unpublished data), 59% of the patients 
treated between 2008 and 2009 were females. Nevertheless, 
IBD is a complex disease that is controlled by multiple risk 
factors,20 and the difference in age of diagnosis between 
genders deserves to be further studied.
Our results revealed similar rates of fistualizing dis-
ease in African-Americans and Caucasians with CD. This 
finding contradicts the concept that African-Americans 
diagnosed with CD have a more severe disease course than 
Caucasians21–22 but is in agreement with Deveaux et al, who 
reported that there was no difference in disease presentation 
between African-American and Caucasian patients who 
required surgery for CD.23 Another study by Mahid et al has 
recently published a systemic review on the comparison of 
the course of IBD between African-Americans and Cauca-
sians among over 2000 cases of IBD and reported similar 
findings to our results.12 Of interest, we found that the rate 
of fistulizing CD among Hispanics was double that of the 
other two ethnic groups. Because there are few published 
data on distribution and manifestation of IBD in Hispanics, 
we were not able to make a comparison with this finding 
in the literature. The Mid-Atlantic Crohn’s Disease Study 
Group conducted a multicenter survey of African-American 
and Caucasian patients with CD who were matched by age, 
gender, and practice type (teaching versus private practice 
setting) and reported that African-American and Caucasian 
patients have similar disease course presentations.24
The utilization of data for constructing the current cross-
sectional study has some shortcomings. First, the   retrospective 
nature of the data collection may be limited by incomplete 
documentation. However, the HCHD has a comprehensive 
system that details all radiology, endoscopy, pathology, and 
laboratory reports – data that are essential in the diagnosis 
and management of patients with IBD. The second limitation 
of the study is that we were not able to examine the effect of 
other races due to their small sample size. However, our study 
is the largest study comparing African-Americans, Hispanics, 
and Caucasians with IBD in the United States to date. In the 
2000 Census, nearly 60% of the Hispanic population in the 
United States was of Mexican descent, which is similar to 
the majority of the Hispanic population of Harris County. 
Therefore, our data reflect the findings of a predominantly 
Mexican-American patient population with IBD. Our results 
could be more representative of the overall indigent Hispanic 
population in the United States. We also found that the three 
studied ethnic groups underwent similar rates of diagnostic 
testing during the study period. Finally, all patients within 
the HCHD have equal access to physicians, hospital facili-
ties, and the pharmacy, thus eliminating potential provider 
or patient bias that may delay the diagnosis.
In conclusion, our study demonstrates clear evidence of 
the importance of the effect of ethnicity on the presentation 
and manifestation of IBD. Hispanics were diagnosed more 
frequently with UC, whereas African-Americans and Cau-
casians were diagnosed more frequently with CD. Females 
were diagnosed with IBD at an older age than males, and the 
difference was consistent for the three racial/ethnic groups. 
Understanding the epidemiology of IBD requires better 
understanding of the interactions between environment, 
ethnic group, age, and socioeconomic conditions.
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